Annovis Bio, Inc.
ANVS
$2.37
-$0.01-0.42%
NYSE
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 17.13M | 22.24M | 10.55M | 12.64M | 4.00M |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 470.60K | 4.49M | 367.40K | 254.80K | 313.00K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 3.85M | 7.50K | 3.01M | 1.47M | 735.70K |
| Total Current Assets | 21.45M | 26.74M | 13.93M | 14.36M | 5.05M |
|
|
|||||
| Total Current Assets | 21.45M | 26.74M | 13.93M | 14.36M | 5.05M |
| Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 21.45M | 26.74M | 13.93M | 14.36M | 5.05M |
|
|
|||||
| Total Accounts Payable | 974.30K | 1.37M | 2.31M | 4.10M | 3.39M |
| Total Accrued Expenses | 1.83M | 1.13M | 1.58M | 1.29M | 662.70K |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 2.81M | 2.50M | 3.88M | 5.39M | 4.06M |
|
|
|||||
| Total Current Liabilities | 2.81M | 2.50M | 3.88M | 5.39M | 4.06M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 319.00K | 179.00K | 737.00K | 1.91M | 2.74M |
| Total Liabilities | 3.12M | 2.68M | 4.62M | 7.30M | 6.80M |
|
|
|||||
| Common Stock & APIC | 164.94M | 164.44M | 144.16M | 136.05M | 114.60M |
| Retained Earnings | -146.61M | -140.39M | -134.85M | -128.98M | -116.35M |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | 18.33M | 24.05M | 9.31M | 7.06M | -1.75M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 18.33M | 24.05M | 9.31M | 7.06M | -1.75M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 18.33M | 24.05M | 9.31M | 7.06M | -1.75M |
|
|
|||||